Residual Neuromuscular Block Remains a Safety Concern for Perioperative Healthcare Professionals: A Comprehensive Review

Residual Neuromuscular Block Remains a Safety Concern for Perioperative Healthcare Professionals: A Comprehensive Review

Residual neuromuscular block (RNMB) remains a significant safety concern for patients throughout the perioperative period and is still widely under-recognized by perioperative healthcare professionals. Current literature suggests an association between RNMB and an increased risk of postoperative pul...

Full description

Bibliographic Details
Main Authors:	Franziska Elisabeth Blum, Andrew R. Locke, Naveen Nathan, Jeffrey Katz, David Bissing, Mohammed Minhaj, Steven B. Greenberg
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Journal of Clinical Medicine
Subjects:	anesthesia perioperative care residual neuromuscular block quantitative monitoring neuromuscular blocking agent
Online Access:	https://www.mdpi.com/2077-0383/13/3/861

Similar Items

Neuromuscular Characteristics of Rocuronium in Diabetic Patients
by: Ahmet Topal, et al.
Published: (2014-08-01)

A surgeon′s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
by: James J Lamberg, et al.
Published: (2013-01-01)

Focus on the agents most frequently responsible for perioperative anaphylaxis
by: E. Di Leo, et al.
Published: (2018-07-01)

The latest trend in neuromuscular monitoring: return of the electromyography
by: Wonjin Lee
Published: (2021-04-01)

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction
by: Hans D de Boer, et al.
Published: (2018-11-01)

Neuromuscular block in patients 80 years and older: a prospective, controlled study
by: Denis Schmartz, et al.
Published: (2021-09-01)

Farmacodinâmica do cisatracúrio no transplante renal Farmacodinámica del cisatracúrio en el transplante renal Cisatracurium pharmacodynamics in renal transplantation
by: Ismar Lima Cavalcanti, et al.
Published: (2002-06-01)

Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management
by: HaoTian Wu, et al.
Published: (2022-04-01)

Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study
by: M. Carron, et al.
Published: (2022-01-01)

Rate of residual neuromuscular block using single-dose rocuronium in general anesthesia for ENT surgery: a retrospective cohort study
by: Orlando Carrillo-Torres, et al.
Published: (2023-04-01)

New way of dosing sugammadex for termination of vecuronium induced neuromuscular block
by: Blaž Peček, et al.
Published: (2015-06-01)

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
by: Yong Byum Kim, et al.
Published: (2017-10-01)

THE MOST COMMONLY IDENTIFIED CAUSE OF PERIOPERATIVE HYPERSENSITIVITY REACTIONS
by: Silviya M. Novakova, et al.
Published: (2019-02-01)

Phenobarbital influence on neuromuscular block produced by rocuronium in rats Influência do fenobarbital no bloqueio neuromuscular produzido pelo rocurônio em ratos
by: Angélica de Fátima de Assunção Braga, et al.
Published: (2008-08-01)

A multicenter survey on the use of neuromuscular blockade in Greece. Does the real-world clinical practice indicate the necessity of guidelines?
by: Chrysanthi Batistaki, et al.
Published: (2019-01-01)

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
by: Khawaja Rashid Hafeez, et al.
Published: (2018-07-01)

Examining influences of neuromuscular block post tetanic monitoring technique on the quality of surgical conditions: Neuromuscular block and quality of surgical conditions
by: Janković Radmilo, et al.
Published: (2016-01-01)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
by: Sung-Ae Cho, et al.
Published: (2022-04-01)

REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study)
by: Massimiliano Greco, et al.
Published: (2023-01-01)

Practice Guidelines for Monitoring Neuromuscular Blockade—Elements to Change to Increase the Quality of Anesthesiological Procedures and How to Improve the Acceleromyographic Method
by: Urszula Kosciuczuk, et al.
Published: (2024-03-01)

Effects of hydrocortisone-presensitized sugammadex on recovery from neuromuscular blockade induced by rocuronium: a rodent in vivo study
by: Hey-Ran Choi, et al.
Published: (2022-04-01)

Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study
by: Piet Krijtenburg, et al.
Published: (2024-03-01)

Progress of residual neuromuscular blockade after general anesthesia in elderly patients
by: LIU Qiuli, et al.
Published: (2023-01-01)

Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm
by: Yong Beom Kim, et al.
Published: (2020-06-01)

A Cross-Sectional survey on Knowledge, Attitude, and Practices of Neuromuscular Monitoring among Indian Anesthesiologists
by: Sonal Goyal, et al.
Published: (2022-10-01)

Neuromuscular diseases and anesthesia
by: Antonijević Vesna, et al.
Published: (2018-01-01)

Assessment of the New Acceleromyograph TOF 3D Compared with the Established TOF Watch SX: Bland-Altman Analysis of the Precision and Limits of Agreement between Both Devices—A Randomized Clinical Comparison
by: Stefan Soltesz, et al.
Published: (2022-08-01)

Multidisciplinary Perioperative Care for Children with Neuromuscular Disorders
by: J. Matthew Kynes, et al.
Published: (2018-09-01)

Small doses of epinephrine prolong the recovery from a rocuronium-induced neuromuscular block: a case report
by: Hubert J. Schmitt
Published: (2018-07-01)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
by: Ricardo Vieira Carlos, et al.
Published: (2018-08-01)

Pharmacodynamic interactions between muscle relaxants and other medications in practice of anesthesia
by: Paweł Radkowski, et al.
Published: (2023-05-01)

Preparing for the unexpected: special considerations and complications after sugammadex administration
by: Hajime Iwasaki, et al.
Published: (2017-10-01)

Effective dose of remimazolam co-administered with remifentanil to facilitate I-gel insertion without neuromuscular blocking agents: an up-and-down sequential allocation trial
by: Juyeon Oh, et al.
Published: (2023-03-01)

Circulating microbiome analysis in patients with perioperative anaphylaxis
by: Luc de Chaisemartin, et al.
Published: (2024-01-01)

The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study
by: Faraj K Alenezi, et al.
Published: (2021-05-01)

Neuromuscular blockade management in the critically Ill patient
by: J. Ross Renew, et al.
Published: (2020-05-01)

Feasibility of intraoperative quantitative neuromuscular blockade monitoring in children using electromyography
by: Kwaku Owusu-Bediako, et al.
Published: (2022-01-01)

The antagonistic effect of neostigmine on rocuronium-, clindamycin-, or both-induced neuromuscular blocking in the rat phrenic nerve-hemidiaphragm
by: Seung Soo Kim, et al.
Published: (2011-10-01)

Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial
by: Tom Schepens, et al.
Published: (2019-10-01)

The use of sugammadex in an infant with prolonged neuromuscular blockade - A case report -
by: Hyunho Kim, et al.
Published: (2022-01-01)